Hansard

I thank my colleague Clare Adamson for again raising awareness of pancreatic cancer. I have tried to participate in the debate on the subject each year in which I have been a member of the Parliament and in memory of my mother, who died from the disease in 1985—some 40 years ago—at the age of only 52. Although it remains one of the most stubborn cancers, progress is being made, with the emphasis on early detection of the vague symptoms that it presents. This will be the last time that I make such a contribution, but I will look in next year to hear the debate and to continue my support for the work that is being done to battle the cancer.

I am grateful to Pancreatic Cancer UK for its briefing. Among the stats and information that it provided, one thing stood out for me—that 80 per cent of people with pancreatic cancer are diagnosed too late. Some members have mentioned that. I hope that that frightening statistic will alert the public to take seriously some of the vague symptoms that can appear. Early detection and diagnosis hold the key to more treatment options and lead to better survival rates.

Clare Adamson and other members have described those vague symptoms, and we need to repeat them—it is always worth doing that. Unexplained weight loss, indigestion, stomach and back pain, new-onset diabetes and even yellowing of the skin have already been mentioned by members, but we have to get that message through to the public. Folk should visit their GP to begin the process of being checked out if they experience those symptoms. Interestingly, around one in five people over the age of 60—as I am—will already have a pancreatic cyst, but only a small percentage of those will develop into pancreatic cancer.

I will take a brief look at some of the research that is going on. At the University of Glasgow, there is work being done to identify the features of higher-risk cysts in order to help doctors make the important treatment decisions. At the University of Liverpool, a test has been developed to identify type 3c diabetes, which may be an early indicator and an early warning sign. As Clare Adamson mentioned, Imperial College London is developing a breath test—a world first—that GPs could perform directly, after which they could make further referrals if need be. At the University of Essex, a new blood test is being developed that can help with early detection. Those are just a few examples of the fantastic work that is going on, which I hope will make a real difference to survival rates from the cancer.

We hear that family inheritance also plays a part. One in 10 cases are connected with inheritance. Even more work is being done on that, through the family history checker. I wish that some of that work had been funded 40 years ago.

I turn to some asks of the Government—basically, that it offers more support for diagnostic capacity across Scotland. If we are alerting the public to issues and conditions that may be a cause for concern, we need to provide people with easy, localised access to get the help that they might need. We need a centralised service to co-ordinate the family inheritance effort and to identify high-risk individuals across multiple cancer types.

Perhaps, in this day and age, we also need a wee bit more help from artificial intelligence, with the analytics and data analysis that are making great strides in medical science elsewhere. I know that the universities of Strathclyde and Glasgow are deploying AI techniques in their research, and I wish them good luck with that work. I wish all who are engaged in the research the very best of luck, and I ask the Scottish Government to help as best we can to support the research that might help us to begin to win the battle against pancreatic cancer.

Lastly, I thank my colleague Clare Adamson for again bringing the issue to the attention of the Scottish people, through their Parliament.